Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1924 1
1928 1
1948 1
1950 1
1965 1
1970 2
1974 3
1975 12
1976 17
1977 13
1978 4
1979 2
1980 6
1981 5
1982 12
1983 17
1984 26
1985 13
1986 16
1987 13
1988 28
1989 15
1990 9
1991 23
1992 18
1993 30
1994 25
1995 25
1996 20
1997 25
1998 30
1999 31
2000 33
2001 33
2002 40
2003 32
2004 33
2005 26
2006 33
2007 32
2008 31
2009 22
2010 32
2011 29
2012 26
2013 22
2014 13
2015 12
2016 20
2017 10
2018 5
2019 8
2020 7
2021 5
2022 2
2023 5
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

913 results

Results by year

Filters applied: . Clear all
Page 1
Bone metastases.
Coleman RE, Croucher PI, Padhani AR, Clézardin P, Chow E, Fallon M, Guise T, Colangeli S, Capanna R, Costa L. Coleman RE, et al. Nat Rev Dis Primers. 2020 Oct 15;6(1):83. doi: 10.1038/s41572-020-00216-3. Nat Rev Dis Primers. 2020. PMID: 33060614 Review.
Adjuvant Endocrine Therapy in Premenopausal Breast Cancer: 12-Year Results From SOFT.
Francis PA, Fleming GF, Láng I, Ciruelos EM, Bonnefoi HR, Bellet M, Bernardo A, Climent MA, Martino S, Bermejo B, Burstein HJ, Davidson NE, Geyer CE Jr, Walley BA, Ingle JN, Coleman RE, Müller B, Le Du F, Loibl S, Winer EP, Ruepp B, Loi S, Colleoni M, Coates AS, Gelber RD, Goldhirsch A, Regan MM; SOFT Investigators and the International Breast Cancer Study Group (a division of ETOP IBCSG Partners Foundation). Francis PA, et al. Among authors: coleman re. J Clin Oncol. 2023 Mar 1;41(7):1370-1375. doi: 10.1200/JCO.22.01065. Epub 2022 Dec 9. J Clin Oncol. 2023. PMID: 36493334 Free PMC article. Clinical Trial.
Bisphosphonates in oncology.
Coleman RE, McCloskey EV. Coleman RE, et al. Bone. 2011 Jul;49(1):71-6. doi: 10.1016/j.bone.2011.02.003. Epub 2011 Feb 21. Bone. 2011. PMID: 21320652 Review.
Bisphosphonates: clinical experience.
Coleman RE. Coleman RE. Oncologist. 2004;9 Suppl 4:14-27. doi: 10.1634/theoncologist.9-90004-14. Oncologist. 2004. PMID: 15459426 Free article. Review.
Endocrine aspects of bone metastases.
Hofbauer LC, Rachner TD, Coleman RE, Jakob F. Hofbauer LC, et al. Among authors: coleman re. Lancet Diabetes Endocrinol. 2014 Jun;2(6):500-12. doi: 10.1016/S2213-8587(13)70203-1. Epub 2014 Jan 24. Lancet Diabetes Endocrinol. 2014. PMID: 24880565 Review.
Management of cancer treatment-induced bone loss.
Coleman RE, Rathbone E, Brown JE. Coleman RE, et al. Nat Rev Rheumatol. 2013 Jun;9(6):365-74. doi: 10.1038/nrrheum.2013.36. Epub 2013 Mar 19. Nat Rev Rheumatol. 2013. PMID: 23507900 Review.
Adjuvant therapy with bone-targeted agents.
Wilson C, Coleman RE. Wilson C, et al. Among authors: coleman re. Curr Opin Support Palliat Care. 2011 Sep;5(3):241-50. doi: 10.1097/SPC.0b013e3283499c93. Curr Opin Support Palliat Care. 2011. PMID: 21785355 Review.
Bisphosphonates in breast cancer.
Coleman RE. Coleman RE. Ann Oncol. 2005 May;16(5):687-95. doi: 10.1093/annonc/mdi162. Epub 2005 Mar 31. Ann Oncol. 2005. PMID: 15802276 Free article. Review.
913 results